BACKGROUND: -agonist (SABA); the risk was similar to that of budesonide maintenance therapy plus as-needed SABA. The availability of data from clinical trials designed to better reflect clinical practice would be beneficial. METHODS: We conducted a 52-week, randomized, open-label, parallel-group, co...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!